First-line therapy of generalized infantile myofibromatosis with low-dose vinblastine and methotrexate

Pediatr Blood Cancer. 2009 Feb;52(2):308. doi: 10.1002/pbc.21797.
No abstract available

Publication types

  • Letter

MeSH terms

  • Disease-Free Survival
  • Humans
  • Infant
  • Male
  • Methotrexate / therapeutic use*
  • Myofibromatosis / drug therapy*
  • Remission Induction
  • Vinblastine / therapeutic use*

Substances

  • Vinblastine
  • Methotrexate